News | December 22, 2008

St. Jude Medical Acquires Radi Medical Systems to Expand Cardiovascular Offerings

December 23, 2008 - St. Jude Medical Inc. said this week it completed the acquisition of Radi Medical Systems AB for $250 million in cash.

Radi is a leader in two segments of the market for cardiovascular medical devices in which St. Jude Medical does not currently participate - fractional flow reserve pressure measurement guide wires and manual compression-assist products for vascular closure. For 2008, Radi is expected to generate approximately $80 million in sales, a 19 percent increase over 2007.

Radi’s pressure measurement guide wire, PressureWire Certus, comprises about a 70 percent share of the global market for physiological assessment of coronary lesions. The product is supported by a growing body of clinical evidence, including the FAME (Fractional Flow Reserve vs. Angiography for Multivessel Evaluation) study. The results of the FAME study were presented at the Transcatheter Cardiovascular Therapeutics conference in October 2008. The market for physiological assessment of coronary lesions totaled more than $60 million in 2008 and is projected to continue growing at a strong double-digit rate, St. Jude said

Radi’s FemoStop and RadiStop product lines comprise about a 60 percent share of the global market for manual compression-assist products for vascular closure. This market totaled about $45 million in 2008 and is projected to continue to grow at least at a mid single-digit rate. The FemoStop and RadiStop product lines, together with St. Jude Medical’s Angio-Seal line of active vascular closure products, will be part of an expanded program by St. Jude to develop the potential of a global vascular closure device market that is only about 27 percent penetrated, the company said.

With this transaction, Radi Medical Systems will become part of the St. Jude Medical Cardiovascular Division. The transaction is expected to be neutral to St. Jude Medical’s consolidated earnings per share in 2009 and is expected to be positive to consolidated earnings per share beginning in 2010. St. Jude Medical funded the acquisition with cash on hand outside the U.S. as well as with the proceeds from a new three-year term loan established recently with a syndicate of banks.

For more information:,,

Related Content

BioCardia Initiates Commercial Release of Avance Steerable Introducer
News | Catheters | October 23, 2019
BioCardia announced the U.S. commercial availability of its Avance Bi-Directional Steerable Introducer Sheath for...
Cook Medical Launches 2.6 Fr CXI Support Catheter
Technology | Catheters | August 23, 2019
August 23, 2019 — Cook Medical recently released the second generation of the 2.6 Fr CXI...
Biocardia Receives FDA Clearance for Avance Steerable Introducer Family
Technology | Catheters | May 16, 2019
BioCardia Inc. announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Avance steerable introducer...
Navitian Coronary Microcatheter Receives CE Mark Approval
News | Catheters | February 21, 2019
Navitian, the new coronary microcatheter from iVascular, recently received CE mark approval. The device was approved to...
First U.S. Patients Treated With OrbusNeich Teleport Microcatheter
News | Catheters | January 31, 2019
Cardiovascular Systems Inc. announced that the first patients in the United States were treated using the OrbusNeich...
Merit Medical Acquires Assets of Vascular Insights LLC
News | Catheters | December 18, 2018
Merit Medical Systems Inc. announced that it has acquired substantially all of the assets of Vascular Insights LLC,...
Reflow Medical's Wingman Crossing Catheter Receives FDA Clearance for Coronary Indication
News | Catheters | October 02, 2017
October 2, 2017 — Reflow Medical Inc. announced that the company has received 510(k) clearance from the U.S.
Roxwood Medical Announces Agreement With Abbott for U.S. Product Distribution
News | Catheters | August 09, 2017
Roxwood Medical Inc. recently announced it has entered into an exclusive agreement with Abbott for distribution of...
Teleflex, FDA 510k clearance, TrapLiner Catheter, U.S. launch
Technology | Catheters | March 02, 2017
Teleflex Inc. has announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and U.S. commercial launch...
Merit Medical Systems, SwiftNINJA Steerable Microcatheter, FDA 510(k) clearance
Technology | Catheters | November 09, 2016
November 9, 2016 — Merit Medical Systems Inc.